Difference between revisions of "Talk:Sequence-based mutation analysis TSD"
From Bioinformatikpedia
Rackersederj (talk | contribs) |
|||
| Line 9: | Line 9: | ||
Nevertheless some little notes (typos italic): |
Nevertheless some little notes (typos italic): |
||
| − | * ''SNPs a'''l'''e listed'' |
||
* I've actually never heard of the Grantham score before (not sure if I should admit that - sounds interesting in this case) |
* I've actually never heard of the Grantham score before (not sure if I should admit that - sounds interesting in this case) |
||
| − | * ''displayed as it is '''nor''' part of the pdb reference structure'' |
||
* "PAM1 and PAM250 are the extremes for this type of substitution matrix and might not be the most commonly applied ones." I think that PAM250 is used quite often, whereas PAM1 almost never |
* "PAM1 and PAM250 are the extremes for this type of substitution matrix and might not be the most commonly applied ones." I think that PAM250 is used quite often, whereas PAM1 almost never |
||
| − | * ''three stru'''cutre'''-based''* |
||
| − | * ''Obser'''b'''ing'' |
||
--[[User:Rackersederj|Rackersederj]] 19:31, 18 June 2012 (UTC) |
--[[User:Rackersederj|Rackersederj]] 19:31, 18 June 2012 (UTC) |
||
| + | |||
| + | ** Typos so far corrected, thank you ! --Ali |
||
Revision as of 21:30, 18 June 2012
Please use the following positions for this task:
R178H E482K L451V S210F L39R R170W D258H M1V L127R C58Y --Joerdensv 20:55, 12 June 2012 (UTC)
It is possible (if not probable) that we will not be able to finish this task. We apologise for the inconvenience !!!
Nevertheless some little notes (typos italic):
- I've actually never heard of the Grantham score before (not sure if I should admit that - sounds interesting in this case)
- "PAM1 and PAM250 are the extremes for this type of substitution matrix and might not be the most commonly applied ones." I think that PAM250 is used quite often, whereas PAM1 almost never
--Rackersederj 19:31, 18 June 2012 (UTC)
- Typos so far corrected, thank you ! --Ali
